Cocrystal Pharma, Inc. — Director's Dealing 2019

Oct 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2019-10-23

Reporting Person: Schinazi Raymond F (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-23	Common Stock	P	3935	$1.0386	Acquired	9244863	Direct
2019-10-24	Common Stock	P	5094	$1.15	Acquired	9249957	Direct
2019-10-25	Common Stock	P	7906	$1.15	Acquired	9257863	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	995593	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.965 to $1.08, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote of this Form 4.